Bacterial lipopolysaccharide and phospholipid membranes — Drug Target
All drugs that target Bacterial lipopolysaccharide and phospholipid membranes — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- Colistimethate sodium for injection · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Polymyxin antibiotic · Infectious Disease
Colistimethate sodium is a prodrug of colistin that disrupts bacterial cell membranes by binding to lipopolysaccharides and phospholipids, leading to cell lysis and death.